The Earthtimes online News
Home

The Jean Coutu Group-Second Quarter Results

Posted : Mon, 06 Oct 2008 11:01:25 GMT
Author : The Jean Coutu Group (PJC) Inc.
Category : Press Release
News Alerts by Email click here )
Create your own RSS
News | Home
LONGUEUIL, QUEBEC -- 10/06/08 -- The Jean Coutu Group (PJC) Inc. (the "Company" or the "Jean Coutu Group") (TSX: PJC.A) today reported its financial results for the second quarter and fiscal period ended August 30, 2008.


                               SUMMARY OF RESULTS
(Unaudited, in millions of Canadian dollars except per share amounts)

-------------------------------------------------------------------------

                Q2-2009    Q1-2008 (1)   Year-to-date   Comparable period
                                                 2009        2007-2008 (2)
-------------------------------------------------------------------------

Revenues
  Canada          567.5         540.3         1,141.8             1,088.7
  United States       -             -               -             2,708.9
-------------------------------------------------------------------------
                  567.5         540.3         1,141.8             3,797.6
-------------------------------------------------------------------------
-------------------------------------------------------------------------

Operating income
 before
 amortization
 ("OIBA")
  Canada           56.8          54.1           111.2               109.8
  United States       -             -               -                63.4
-------------------------------------------------------------------------
                   56.8          54.1           111.2               173.2
-------------------------------------------------------------------------
-------------------------------------------------------------------------

Share of loss of
 Rite Aid
 Corporation       73.1          29.6           126.5                29.6

Net earnings
 (loss)           (39.1)          8.3           (59.3)                1.9
 Per share        (0.16)         0.03           (0.24)               0.01

Earnings before
 specific items
 and share of
 Rite Aid's
 loss              34.2          33.2            67.4                58.3
 Per share         0.14          0.12            0.27                0.22

(1) The comparative figures used for the second quarter fiscal 2009 results
    for the period ended August 30, 2008 are from the comparable 13-week
    period ended September 1, 2007, which represented the first quarter of
    fiscal 2008.

(2) The comparative figures used for the fiscal period results ended August
    30, 2008 are from the comparable 26-week period ended September 1,
    2007, which included the fourth quarter of fiscal 2007 and the first
    quarter of fiscal 2008.
-------------------------------------------------------------------------

HIGHLIGHTS

- Revenues of the Canadian operations increased by 5.0% to $567.5 million over the comparable 13-week period, which was the first quarter of fiscal 2008 due to the change in the fiscal year-end date.

- The Company recorded its share of Rite Aid's results during the second quarter of fiscal 2009, which amounted to a loss of $73.1 million ($0.30 after-tax per Jean Coutu Group share). Earnings before specific items and share of Rite Aid's loss amounted to $0.14 per share in the second quarter of fiscal 2009 compared with $0.12 per share in the first quarter of fiscal 2008.

- During the second quarter of fiscal 2009, the Company purchased 6.2 million Class A subordinate voting shares at an average price of $7.51 per share for a total amount of $46.7 million under a Normal Course Issuer Bid. These shares were cancelled as of August 30, 2008.

Financial results

"During the second quarter we continued to pursue our growth objective and stepped up the pace of development of the PJC drugstore network, completing a number of initiatives. The Company is well on its way to achieving significant growth in its network selling square footage in fiscal 2009 as we continue to build upon The Jean Coutu Group's position as a leader in pharmacy," said Francois J. Coutu, President and Chief Executive Officer. "Rite Aid took steps to increase its financial flexibility, has largely completed the integration of Brooks Eckerd and announced key appointments to strengthen its senior leadership team."

Presentation of financial statements

The fiscal year ended March 1, 2008 exceptionally contained 38 weeks and 5 days due to the Company's change in fiscal year end. The discussion that follows provides an analysis of the consolidated operating results based on periods in order to provide meaningful analysis for readers. The comparative figures used for discussion and analysis of the Company's second quarter fiscal 2009 ("Q2-2009") results for the period ended August 30, 2008 are from the comparable 13-week period ended September 1, 2007, which was the first quarter of fiscal 2008 ("Q1-2008"). The comparable 26-week period is composed of figures from the fourth quarter of fiscal 2007 and the first quarter of fiscal 2008.

Net loss

For the second quarter of fiscal 2009, the net loss amounted to $39.1 million ($0.16 per share) compared with net earnings of $8.3 million ($0.03 per share) for the first quarter of fiscal 2008. The first six months net loss was $59.3 million ($0.24 per share) compared with net earnings of $1.9 million ($0.01 per share) for the comparable period.

Canadian network sales increased year-over-year and operating income increased by 4.1% to $51.3 million compared with $49.3 million during the comparable 13-week period. Pharmacy script count growth was robust while pharmacy sales growth was impacted by the recent reduction in the prices of generic drugs implemented last fiscal quarter. Operating results were impacted by a change in sales mix and generic drug price reductions.

In fiscal 2009, the Company changed its method of invoicing certain vendor revenues to one based on purchase volumes from the one based principally on expense reimbursement used previously. Consequently, these revenues are now recorded as a reduction of the cost of goods sold account. In fiscal 2008, vendor revenues and expenses related thereto were recorded on a net basis in general and operating expenses, with the excess, if any, in the cost of goods sold account.

As Pro-Doc continues to expand its product offering and grow its sales, the Company expects to reduce the impact of the reduction of the maximum wholesaler margin for prescription drug distribution which was fixed at 6% in February 2008. Increasing revenues and managing expenses as the Company continues its growth under current market conditions is the top priority.

The Company recorded its share of Rite Aid's results during the second quarter of fiscal 2009. The share of Rite Aid's loss in the Company's second quarter fiscal 2009 earnings amounted to $73.1 million ($0.30 after-tax per Jean Coutu Group share) compared with $29.6 million ($24.8 million or $0.09 after tax per Jean Coutu Group share) during the comparable period last fiscal year.

Earnings before specific items and the share of Rite Aid's loss amounted to $34.2 million ($0.14 per share) during the second quarter of fiscal 2009 compared with $33.2 million ($0.12 per share) for the fiscal quarter ended September 1, 2007. Earnings before specific items and the share of Rite Aid's loss amounted to $67.4 million ($0.27 per share) during the first six months of fiscal 2009 compared with $58.3 million ($0.22 per share) for the comparable period.

Canadian Operations

Retail sales

Retail sales growth percentages quoted herein are based on comparable periods.

During the second quarter, the Company's Canadian franchise network showed a 4.9% increase in total retail sales compared with the comparable period. Network retail sales were up 3.6%, pharmacy sales gained 5.7% and front-end sales decreased 0.5% year-over-year in terms of comparable stores. This quarter's front-end sales growth was impacted by inclement weather and a slowdown in consumer spending. Retail sales for the period were $823.6 million.

For the 26-week period, on a same-store basis, total PJC network retail sales advanced 4.0%, pharmaceutical sales gained 6.2% and front-end sales remained level with last year.


--------------------------------------------------------------------------
RETAIL SALES GROWTH    Q2-2009   Q1-2008   Year-to-date  Comparable period
  (Unaudited)                                      2008          2007-2008
--------------------------------------------------------------------------

CANADA (1)
Total sales growth
Total                      4.9%      7.4%           5.0%               7.2%
Pharmacy                   6.9%      9.3%           7.1%               8.9%
Front-end                  0.8%      4.5%           1.1%               4.5%
Same store sales
 growth
Total                      3.6%      7.0%           4.0%               6.7%
Pharmacy                   5.7%      9.1%           6.2%               8.7%
Front-end                 -0.5%      3.7%           0.0%               3.7%

(1) Franchised outlets' retail sales are not included in the Company's
    consolidated financial statements.
--------------------------------------------------------------------------

Distribution center sales

Canadian operations distribution center sales amounted to $509.9 million in the second quarter of fiscal 2009 compared with $486.1 million for the fiscal quarter ended September 1, 2007, an increase of 4.9%.

OIBA

OIBA for Canadian operations amounted to $56.8 million in the second quarter of fiscal 2009 compared with $54.1 million for the first quarter of fiscal 2008, an increase of 5.0%. The increase in OIBA is attributable to an increase in revenues, a change in sales mix and generic drug price reductions which were offset the increase in the wholesaler margin for prescription drug distribution from 5% in the first quarter of fiscal 2008 to 6% in the current quarter. OIBA as a percentage of revenues for Canadian operations ended the fiscal quarter at 10.0%, the same level as in the first quarter of fiscal 2008.

OIBA as a percentage of revenues for Canadian operations ended the 26-week period at 9.7% compared with 10.1% for the comparable period.

Store network development

During the second quarter of fiscal 2009, there were 8 store openings including five acquisitions and one relocation. On August 30, 2008, there were 343 stores in the PJC Jean Coutu drugstore network.

Rite Aid investment

The Company held a 29.9% equity interest in Rite Aid as of August 30, 2008 and this investment is accounted for under the equity method. Rite Aid reported a net loss for the quarter ended August 30, 2008 of US$222.0 million (US$0.27 per Rite Aid share) compared with US$69.6 million (US$0.10 per Rite Aid share) for the same period the previous fiscal year.

The share of Rite Aid's loss in The Jean Coutu Group's second quarter 2009 earnings amounted to $73.1 million ($0.30 after-tax per Jean Coutu Group share) compared with $29.6 million ($24.8 million or $0.09 after-tax per Jean Coutu Group share) during the first quarter of fiscal 2008.

Normal Course Issuer Bid

On July 8, 2008, the Company announced its intention to purchase for cancellation up to 12,311,000 of its outstanding Class A subordinate voting shares, representing approximately 10% of the current public float of such shares, over a 12-month period ending no later than July 10, 2009.

During the second quarter of fiscal 2009, the Company purchased 6,211,956 Class A subordinate voting shares at an average price of $7.51 per share for a total amount of $46.7 million. These shares were cancelled as of August 30, 2008. During the fiscal 2008, the Company purchased 13,672,800 Class A subordinate voting shares at a weighted average price of $12.93 per share pursuant to a Normal Course Issuer Bid.

The Company has determined that the purchase of its Class A shares allows it to optimize its capital structure and create long-term value for shareholders.

Board of Directors

In late July 2008, M. Erik Peladeau, Vice-Chairman of the Board of Quebecor Inc., announced that he was leaving the Board of Directors of The Jean Coutu Group after 15 years of service. M. Peladeau was a long-serving director, having joined the Board of the Company in 1993. The shareholders and directors are grateful for his contribution to our success.

Dividend

The Board of Directors declared a quarterly dividend of $0.04 per share payable on October 31, 2008 to all holders of Class A shares and holders of Class B shares listed in the Company's shareholder ledger as at October 17, 2008.

Outlook

With operations in Canada, financial flexibility and a significant interest in a United States' drugstore leader, the Company is well positioned to capitalize on the growth in the North American drugstore retailing industry. Demographic trends in Canada and the United States are expected to contribute to growth in the consumption of prescription drugs, and to the increased use of pharmaceuticals as the primary intervention in individual healthcare. Management believes that these trends will continue and that the Company will grow its revenues through differentiation and quality of offering and service levels in its Canadian drugstore network, which it operates with a focus on sales growth, its real estate program and operating efficiency.

Conference call

Financial analysts are invited to attend the second quarter results conference call to be held on October 6, 2008, at 9:00 AM (ET). The toll free call-in number is 1-888-789-9572 - access code 3268761 followed by pound sign (#). Media and other interested individuals are invited to listen to the live or deferred broadcast on The Jean Coutu Group corporate website at www.jeancoutu.com. A full replay will also be available by dialing 1-800-408-3053 - access code 3268761 followed by pound sign (#) until November 7, 2008.

Supporting documentation (Management's discussion and analysis and investor presentation) is available at www.jeancoutu.com using the investors' link. Readers may also access additional information and filings related to the Company using the following link to the www.sedar.com website.

About The Jean Coutu Group

The Jean Coutu Group (PJC) Inc. operates a network of 343 franchised drugstores in Canada located in the provinces of Quebec, New Brunswick and Ontario (under the banners of PJC Jean Coutu, PJC Clinique and PJC Sante Beaute) and employs more than 16,000 people. The Jean Coutu Group is one of the most trusted names in Canadian pharmacy retailing. The Company holds a significant interest in Rite Aid Corporation, one of the United States' leading drugstore chains with approximately 5,000 drugstores in 31 states and the District of Columbia.

This press release contains forward-looking statements, that involve risks and uncertainties, and which are based on the Company's current expectations, estimates, projections and assumptions and were made by The Jean Coutu Group in light of its experience and its perception of historical trends. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, costs, operating or financial results, are forward-looking statements. All statements other than statements of historical facts included in this press release, including, statements regarding the prospects of the Company's industry and the Company's prospects, plans, financial position and business strategy, may constitute forward-looking statements within the meaning of the Canadian securities legislation and regulations. Some of the forward-looking statements may be identified by the use of forward-looking terminology such as "may," "will," "expect," "intend," "estimate," "project", "could", "anticipate," "plan," "foresee," "believe" or "continue" or the negatives of these terms or variations of them or similar terminology. Although The Jean Coutu Group believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. These statements do not reflect the potential impact of any non-recurring items or of any mergers, acquisitions, dispositions, asset write-downs or other transactions or charges that may be announced or that may occur after the date hereof. While the below list of cautionary statements is not exhaustive, some important factors that could affect our future operating results, financial position and cash flows and could cause our actual results to differ materially from those expressed in these forward-looking statements are the investment in Rite Aid, general economic, financial or market conditions, the investment in ABCP, the cyclical and seasonal variations in the industry in which we operate, the changes in the regulatory environment as it relates to the sale of prescription drug, the ability to attract and retain pharmacists, the intensity of competitive activity in the industry in which we operate, certain property and casualty risks, risks in connection with third party service providers, technological changes that affect demand for our products and services, labour disruptions, including possibly strikes and labour protests, changes in laws and regulations, or in their interpretations, changes in tax regulations and accounting pronouncements, the success of the Company's business model, the supplier and brand reputations and the accuracy of management's assumptions and other factors that are beyond our control.

These and other factors could cause our actual performance and financial results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. Investors and others are cautioned that undue reliance should not be placed on any forward-looking statements. For more information on the risks, uncertainties and assumptions that would cause the Company's actual results to differ from current expectations, please also refer to the Company's public filings available at www.sedar.com and www.jeancoutu.com. In particular, further details and descriptions of these and other factors are disclosed in the Company's Annual Information Form under "Risk Factors" and in the "Risks and Uncertainties" section of the Management's Discussion & Analysis. We expressly disclaim any obligation or intention to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by the applicable securities laws.

This press release also contains certain non-GAAP financial measures. Such information is reconciled to the most directly comparable financial measures, as set forth in the Management's Discussion & Analysis, included in the Company's Second Quarter Report to Shareholders.


Consolidated statements of earnings
                                        13 weeks                  26 weeks
For the periods ended August 30,
 2008 and September 1, 2007      2008       2007         2008         2007
--------------------------------------------------------------------------
--------------------------------------------------------------------------
 (unaudited, in millions of
 Canadian dollars, unless
 otherwise noted)                   $          $            $            $

Sales                           509.9      486.1      1,026.6      3,684.1
Other revenues                   57.6       54.2        115.2        113.5
--------------------------------------------------------------------------
                                567.5      540.3      1,141.8      3,797.6
Operating expenses
  Cost of goods sold            465.1      443.0        936.9      2,899.3
  General and operating
   expenses                      47.0       44.2         96.4        697.9
  Restructuring charges             -          -            -         29.3
  Amortization                    4.1        3.8          8.0          7.6
--------------------------------------------------------------------------
                                516.2      491.0      1,041.3      3,634.1
--------------------------------------------------------------------------
Operating income                 51.3       49.3        100.5        163.5
Financing expenses                1.5        0.3          2.8         75.6
Adjustment to gain (gain) on
 sale of the retail sales
 segment                            -        0.2            -       (143.9)
Loss on early debt retirement       -          -            -        178.9
--------------------------------------------------------------------------
Earnings before the following
 items                           49.8       48.8         97.7         52.9
Share of loss from investments
 subject to significant
 influence                       73.1       29.6        126.5         29.6
Income taxes                     15.8       10.9         30.5         21.4
--------------------------------------------------------------------------
Net earnings (loss)             (39.1)       8.3        (59.3)         1.9
--------------------------------------------------------------------------
--------------------------------------------------------------------------

Earnings (loss) per share,
 in dollars
  Basic                         (0.16)      0.03        (0.24)        0.01
  Diluted                       (0.16)      0.03        (0.24)        0.01
--------------------------------------------------------------------------
--------------------------------------------------------------------------



Consolidated statements of comprehensive income
                                        13 weeks                  26 weeks
For the periods ended August
 30, 2008 and September 1, 2007  2008       2007         2008         2007
--------------------------------------------------------------------------
--------------------------------------------------------------------------
(unaudited, in millions of
 Canadian dollars)                  $          $            $            $

Net earnings (loss)             (39.1)       8.3        (59.3)         1.9
Other comprehensive income
 (loss)
  Foreign currency translation
   adjustments                   72.8       (3.2)        84.3         77.3
  Income taxes on the above item    -        0.4            -          1.0
--------------------------------------------------------------------------
                                 72.8       (2.8)        84.3         78.3
--------------------------------------------------------------------------
Comprehensive income             33.7        5.5         25.0         80.2
--------------------------------------------------------------------------
--------------------------------------------------------------------------

The segmented information are an integral part of these unaudited interim
consolidated financial statements.



Consolidated statements of changes in shareholders' equity

                                        13 weeks                  26 weeks
For the periods ended August 30,
 2008 and September 1, 2007      2008       2007         2008         2007
--------------------------------------------------------------------------
--------------------------------------------------------------------------
(unaudited, in millions of
 Canadian dollars)                  $          $            $            $

Capital stock, beginning
 of period                      715.4      789.6        715.4        789.5
  Redemption of stock           (33.9)      (0.2)       (33.9)        (0.2)
  Options exercised                 -        0.2            -          0.3
--------------------------------------------------------------------------
Capital stock, end of period    681.5      789.6        681.5        789.6
--------------------------------------------------------------------------
--------------------------------------------------------------------------

Contributed surplus,
 beginning of period             19.7        4.8         16.7          4.5
  Stock-based compensation cost   0.2        1.9          0.5          2.2
  Stock-based compensation from
   investment subject to
   significant influence -
   Rite Aid                       2.4          -          5.1            -
--------------------------------------------------------------------------
Contributed surplus, end
 of period                       22.3        6.7         22.3          6.7
--------------------------------------------------------------------------
--------------------------------------------------------------------------

Retained earnings, beginning
 of period                      900.6    1,319.7        930.8      1,333.9
  Impact of the adoption of
   new accounting standards         -       (4.5)           -         (4.5)
  Net earnings (loss)           (39.1)       8.3        (59.3)         1.9
--------------------------------------------------------------------------
                                861.5    1,323.5        871.5      1,331.3
Dividends                        (9.6)     (10.4)       (19.6)       (18.2)
Excess of purchase price over
 carrying value of Class A
 subordinate voting shares
 acquired                       (12.8)      (0.5)       (12.8)        (0.5)
--------------------------------------------------------------------------
Retained earnings, end of
 period                         839.1    1,312.6        839.1      1,312.6
--------------------------------------------------------------------------
--------------------------------------------------------------------------

Accumulated other
 comprehensive income (loss),
 beginning of period           (167.3)     (96.6)      (178.8)      (177.7)
  Foreign currency translation
   adjustments, net of income
   taxes                         72.8       (2.8)        84.3         78.3
--------------------------------------------------------------------------
Accumulated other comprehensive
 income (loss), end of period   (94.5)     (99.4)       (94.5)       (99.4)
--------------------------------------------------------------------------
--------------------------------------------------------------------------

--------------------------------------------------------------------------
Total shareholders' equity    1,448.4    2,009.5      1,448.4      2,009.5
--------------------------------------------------------------------------
--------------------------------------------------------------------------

The segmented information are an integral part of these unaudited interim
consolidated financial statements.



Consolidated balance sheets                           As at          As at
                                                  August 30,       March 1,
                                                       2008           2008
--------------------------------------------------------------------------
--------------------------------------------------------------------------
(in millions of Canadian dollars)                         $              $
                                                 (unaudited)      (audited)

Assets
 Current assets
 Accounts receivable                                  173.0          167.9
 Inventories                                          141.2          154.7
 Prepaid expenses                                       6.4            5.2
--------------------------------------------------------------------------
                                                      320.6          327.8
Investments                                         1,108.8        1,143.2
Capital assets                                        343.0          329.3
Goodwill                                               34.5           35.3
Other long-term assets                                145.6          113.7
--------------------------------------------------------------------------
                                                    1,952.5        1,949.3
--------------------------------------------------------------------------
--------------------------------------------------------------------------

Liabilities
Current liabilities
 Accounts payable and accrued liabilities             168.5          201.7
 Income taxes payable                                  35.2           62.9
 Current portion of long-term debt                      3.4            2.0
--------------------------------------------------------------------------
                                                      207.1          266.6
Long-term debt                                        268.2          169.5
Other long-term liabilities                            28.8           29.1
--------------------------------------------------------------------------
                                                      504.1          465.2
--------------------------------------------------------------------------

Shareholders' equity
 Capital stock                                        681.5          715.4
 Contributed surplus                                   22.3           16.7

 Retained earnings                                    839.1          930.8
 Accumulated other comprehensive income (loss)        (94.5)        (178.8)
--------------------------------------------------------------------------
                                                      744.6          752.0
--------------------------------------------------------------------------
                                                    1,448.4        1,484.1
--------------------------------------------------------------------------
                                                    1,952.5        1,949.3
--------------------------------------------------------------------------
--------------------------------------------------------------------------

The segmented information are an integral part of these unaudited interim
consolidated financial statements.



Consolidated statements of cash flows
                                        13 weeks                  26 weeks
For the periods ended August 30,
 2008 and September 1, 2007      2008       2007         2008         2007
--------------------------------------------------------------------------
--------------------------------------------------------------------------
(unaudited, in millions of
 Canadian dollars)                  $          $            $            $

Operating activities
Net earnings (loss)             (39.1)       8.3        (59.3)         1.9
Items not affecting cash
  Amortization                    5.5        4.8         10.7         13.3
  Adjustment to gain (gain)
   on sale of the retail sales
   segment                          -        0.2            -       (143.9)
  Write-off of deferred
   financing fees                   -          -            -         67.9
  Share of loss from investments
   subject to significant
   influence                     73.1       29.6        126.5         29.6
  Future income taxes             2.6       (1.5)         4.7        (37.0)
  Other                          (0.3)       0.4         (0.3)        15.8
--------------------------------------------------------------------------
                                 41.8       41.8         82.3        (52.4)
Net changes in non-cash asset
 and liability items             (6.4)     (23.7)       (58.6)        43.2
--------------------------------------------------------------------------
Cash flow provided by (used in)
 operating activities            35.4       18.1         23.7         (9.2)
--------------------------------------------------------------------------
Investing activities
  Proceeds of disposal from the
   retail sales segment             -          -            -      2,450.1
  Investments                     0.4      (35.2)        (0.8)       (35.4)
  Purchase of capital assets     (7.1)      (5.8)       (21.4)       (25.6)
  Proceeds from disposal of
   capital assets                 0.1        1.3          0.3          6.7
  Other long-term assets        (24.5)         -        (35.3)        (0.4)
--------------------------------------------------------------------------
Cash flow provided by
 (used in) investing
 activities                     (31.1)     (39.7)       (57.2)     2,395.4
--------------------------------------------------------------------------
Financing activities
  Net change in revolving
   credit facility, net of
   costs                         52.0       (0.1)       100.0         (0.1)
  Repayment of long-term debt       -       (0.2)        (0.2)    (2,381.0)
  Issuance of capital stock         -        0.2            -          0.4
  Redemption of capital stock   (46.7)         -        (46.7)           -
  Dividends                      (9.6)     (10.4)       (19.6)       (18.2)
--------------------------------------------------------------------------
Cash flow provided by (used in)
 financing activities            (4.3)     (10.5)        33.5     (2,398.9)
--------------------------------------------------------------------------
Effect of foreign exchange
 rate changes on cash
 and cash equivalents               -          -            -       (114.5)
--------------------------------------------------------------------------
Decrease in cash and cash
 equivalents                        -      (32.1)           -       (127.2)
Cash and cash equivalents,
 beginning of period                -       40.7            -        135.8
--------------------------------------------------------------------------
Cash and cash equivalents,
 end of period                      -        8.6            -          8.6
--------------------------------------------------------------------------
--------------------------------------------------------------------------

The segmented information are an integral part of these unaudited interim
consolidated financial statements.

Consolidated segmented information

For the periods ended August 30, 2008 and September 1, 2007

(unaudited, in millions of Canadian dollars)

The Company has two reportable segments: franchising and retail sales. Within the franchising segment, the Company carries on the franchising activity of the "PJC Jean Coutu" banner, operates two distribution centres and coordinates several other services for the benefit of its franchisees. During the fiscal year 2007, the Company also operated in the retail sales segment through outlets selling pharmaceutical and other products under the "Brooks" and "Eckerd" banners. On June 4, 2007, the Company sold its interest in the "Brooks" and "Eckerd" outlets for cash and an equity interest in Rite Aid Corporation ("Rite Aid"). As a result, the Company's retail sales segment is represented by the investment in Rite Aid.

The Company analyzes the performance of its operating segments based on their operating income before amortization, which is not a measure of performance under Canadian generally accepted accounting principles ("GAAP"). However, management uses this performance measure for assessing the operating performance of its reportable segments.


Segmented information is
 summarized as follows:                 13 weeks                  26 weeks
                                 2008       2007         2008         2007
--------------------------------------------------------------------------
                                    $          $            $            $

Revenues (1)
  Franchising                   567.5      540.3      1,141.8      1,088.7
  Retail sales                      -          -            -      2,708.9
--------------------------------------------------------------------------
                                567.5      540.3      1,141.8      3,797.6
--------------------------------------------------------------------------
--------------------------------------------------------------------------

Operating income before
 amortization
  Franchising                    56.8       54.1        111.2        109.8
  Retail sales                      -          -            -         63.4
--------------------------------------------------------------------------
                                 56.8       54.1        111.2        173.2
--------------------------------------------------------------------------
--------------------------------------------------------------------------

Amortization
  Franchising (2)                 5.5        4.8         10.7          9.7
  Retail sales                      -          -            -         82.2
  Reversal of amortization
   of the retail sales segment
   in consolidation (3)             -          -            -        (82.2)
--------------------------------------------------------------------------
                                  5.5        4.8         10.7          9.7
--------------------------------------------------------------------------
--------------------------------------------------------------------------

Operating income
  Franchising                    51.3       49.3        100.5        100.1
  Retail sales                      -          -            -        (18.8)
  Reversal of amortization
   of the retail sales segment
   in consolidation (3)             -          -            -         82.2
--------------------------------------------------------------------------
                                 51.3       49.3        100.5        163.5
--------------------------------------------------------------------------
--------------------------------------------------------------------------

(1) Revenues include sales and other revenues.
(2) Including amortization of incentives paid to franchisees.
(3) For the period from August 23, 2006 to June 4, 2007, the Company ceased
    amortizing the assets related to its US operations since they were
    classified as assets held for sale.



                                        13 weeks                  26 weeks
                                 2008       2007         2008         2007
--------------------------------------------------------------------------
                                    $          $            $            $

Share of loss from investments
 subject to significant
 influence
  Retail sales (1)               73.1       29.6        126.5         29.6
--------------------------------------------------------------------------
                                 73.1       29.6        126.5         29.6
--------------------------------------------------------------------------
--------------------------------------------------------------------------

Capital assets paid
  Franchising                     7.1        5.8         21.4         13.4
  Retail sales                      -          -            -         12.2
--------------------------------------------------------------------------
                                  7.1        5.8         21.4         25.6
--------------------------------------------------------------------------
--------------------------------------------------------------------------


                                                        As at        As at
                                                    August 30,     March 1,
                                                         2008         2008
--------------------------------------------------------------------------
                                                            $            $

Capital assets and goodwill
  Franchising                                           377.5        364.6
--------------------------------------------------------------------------
                                                        377.5        364.6
--------------------------------------------------------------------------
--------------------------------------------------------------------------

Total assets
  Franchising                                           900.3        860.0
  Retail sales (1)                                    1,052.2      1,089.3
--------------------------------------------------------------------------
                                                      1,952.5      1,949.3
--------------------------------------------------------------------------
--------------------------------------------------------------------------

The Company's revenues, capital assets and goodwill as well as total assets
for the geographic areas of Canada and the United States correspond to the
franchising and retail sales segments respectively.

(1) Represents the Company's equity investment in Rite Aid.



Unaudited additional information
For the periods ended August 30, 2008 and September 1, 2007
(In millions of Canadian dollars except for margins)

                                        13 weeks                  26 weeks
                                 2008       2007         2008         2007
--------------------------------------------------------------------------
                                    $          $            $            $
Canada
  Sales                         509.9      486.1      1,026.6        978.8
  Cost of goods sold            465.1      443.0        936.9        891.5
--------------------------------------------------------------------------
  Gross profit                   44.8       43.1         89.7         87.3
  As a % of sales                 8.8%       8.9%         8.7%         8.9%

  Other revenues (1)             59.0       55.2        117.9        112.0

  General and operating
   expenses                      47.0       44.2         96.4         89.5
--------------------------------------------------------------------------
  Operating income before
   amortization                  56.8       54.1        111.2        109.8
  Amortization (1)                5.5        4.8         10.7          9.7
--------------------------------------------------------------------------
  Operating income               51.3       49.3        100.5        100.1
--------------------------------------------------------------------------
--------------------------------------------------------------------------

(1) Amortization of incentives paid to franchisees is presented in
    amortization instead of being applied against other revenues as in the
    consolidated financial statements.

THE JEAN COUTU GROUP (PJC) INC.

Unaudited additional information

For the periods ended August 30, 2008 and September 1, 2007

(In millions of Canadian dollars)

--------------------------------------------------------------------------

--------------------------------------------------------------------------

Non-GAAP measures - Operating income before amortization ("OIBA") and OIBA before restructuring charges

OIBA and OIBA before restructuring charges are not measures of performance under Canadian generally accepted accounting principles ("GAAP"); however, management uses those performance measures in assessing the operating and financial performance of its reportable segments. Besides, we believe that OIBA and OIBA before restructuring charges are additional measures used by investors to evaluate operating performance and capacity of a company to meet its financial obligations.

However, OIBA and OIBA before restructuring charges are not and must not be used as alternatives to net earnings or cash flow generated by operating activities as defined by GAAP. OIBA and OIBA before restructuring charges are not necessarily indications that cash flow will be sufficient to meet our financial obligations. Furthermore, our definitions of OIBA and OIBA before restructuring charges may not be necessarily comparative to similar measures reported by other companies.

Net earnings (loss), which is a performance measure defined by GAAP, is reconciled hereunder with OIBA and OIBA before restructuring charges.


                                        13 weeks                  26 weeks
                                 2008       2007         2008         2007
--------------------------------------------------------------------------
                                    $          $            $            $

Net earnings (loss)             (39.1)       8.3        (59.3)         1.9
Financing expenses                1.5        0.3          2.8         75.6
Adjustment to gain (gain)
 on sale of the retail sales
 segment                            -        0.2            -       (143.9)
Loss on early debt retirement       -          -            -        178.9
Share of loss from investments
 subject to significant
 influence                       73.1       29.6        126.5         29.6
Income taxes                     15.8       10.9         30.5         21.4
--------------------------------------------------------------------------
Operating income                 51.3       49.3        100.5        163.5
Amortization per financial
 statements                       4.1        3.8          8.0          7.6
Amortization of incentives
 paid to franchisees (1)          1.4        1.0          2.7          2.1
--------------------------------------------------------------------------
Operating income before
 amortization ("OIBA")           56.8       54.1        111.2        173.2
--------------------------------------------------------------------------
--------------------------------------------------------------------------
Restructuring charges               -          -            -         29.3
--------------------------------------------------------------------------
OIBA before restructuring
 charges                         56.8       54.1        111.2        202.5
--------------------------------------------------------------------------
--------------------------------------------------------------------------

(1) Amortization of incentives paid to franchisees is applied against other
    revenues in the consolidated financial statements.

Unaudited additional information

For the periods ended August 30, 2008 and September 1, 2007

(In millions of Canadian dollars except per share amounts)

--------------------------------------------------------------------------

--------------------------------------------------------------------------

Non-GAAP measures - Earnings (loss) before specific items or earnings (loss) per share before specific items

Earnings (loss) before specific items and earnings (loss) per share before specific items are non-GAAP measures. The Company believes that it is useful for investors to be aware of significant items of an unusual or non-recurring nature that have adversely or positively affected its GAAP measures, and that the above-mentioned non-GAAP measures provide investors with a measure of performance with which to compare its results between periods without regard to these items. The Company's measures excluding certain items have no standardized meaning prescribed by GAAP and are not necessarily comparable to similar measures presented by other companies and therefore should not be considered in isolation.

Net earnings (loss) and earnings (loss) per share are reconciled hereunder to earnings (loss) before specific items and earnings (loss) per share before specific items. All amounts are net of income taxes when applicable.


                                        13 weeks                  26 weeks
                                 2008       2007         2008         2007
--------------------------------------------------------------------------
                                    $          $            $            $

Net earnings (loss)             (39.1)       8.3        (59.3)         1.9
Restructuring charges               -          -            -         17.1
Reversal of amortization
 of the retail sales segment
 in consolidation                   -          -            -        (47.9)
Unrealized foreign exchange
 losses (gains) on monetary
 items                            0.2       (0.1)         0.2         10.3
Unrealized losses on
 derivative financial
 instruments                        -          -            -          3.1
Adjustment to gain (gain)
 on sale of the retail sales
 segment                            -        0.2            -        (76.0)
Loss on early debt retirement       -          -            -        125.0
--------------------------------------------------------------------------
Earnings (loss) before specific
 items                          (38.9)       8.4        (59.1)        33.5
--------------------------------------------------------------------------
--------------------------------------------------------------------------

Earnings (loss) per share       (0.16)      0.03        (0.24)        0.01
Restructuring charges               -          -            -         0.06
Reversal of amortization of
 the retail sales segment
 in consolidation                   -          -            -        (0.18)
Unrealized foreign exchange
 losses (gains) on monetary
 items                              -          -            -         0.04
Unrealized losses on
 derivative financial
 instruments                        -          -            -         0.01
Adjustment to gain (gain)
 on sale of the retail sales
 segment                            -          -            -        (0.29)
Loss on early debt retirement       -          -            -         0.48
--------------------------------------------------------------------------
Earnings (loss) per share
 before specific items          (0.16)      0.03        (0.24)        0.13
--------------------------------------------------------------------------
--------------------------------------------------------------------------

Contacts:
Source: The Jean Coutu Group (PJC) Inc.
Andre Belzile
Senior Vice-President, Finance and Corporate Affairs
450-646-9760

Information:
Michael Murray
Director, Investor Relations
450-646-9611, Ext. 1068

Helene Bisson
Director, Public Relations
450-646-9611, Ext. 1165


Copyright © 2008 Market Wire. All rights reserved.



Share on

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 


Choose Theme
Green Earth Blue Earth Orange Earth Purple Earth

Search
 
You can

Current News

News Category
Business
Entertainment
Environment
General
Health
Sports
Technology
World
Add to Google Toolbar
Breaking News
Press Releases

About us | News Archives | Browse old Archive | Feedback | Disclaimer | Mobile/PDA | News Alerts

The views expressed in the articles are not necessarily those of earthtimes.org and we accept no responsibility for the views or opinions
expressed in the articles either direct or indirect.

© 2008 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy